NEUROBO PHARMACEUTICALS INC (NRBO)
US64132R4048 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.47M | -13.97M | -15.28M | -29.68M | -21.31M | |||
| Depreciation Amortization | 6.00K | 20.00K | 50.00K | 50.00K | 20.00K | |||
| Change In Working Capital | 4.40M | -1.17M | -580.00K | 810.00K | 740.00K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | -2.73M | 3.40M | 690.00K | 18.06M | 13.51M | |||
| OPERATING CASH FLOW | -10.80M | -11.71M | -15.13M | -10.76M | -7.04M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -50.00K | 0.00 | 0.00 | 0.00 | -210.00K | |||
| Other Investing Activity | N/A | 10.00K | -580.00K | 70.00K | -5.84M | |||
| INVESTING CASH FLOW | -50.00K | 10.00K | -590.00K | 70.00K | -6.06M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 0.00 | 32.25M | 24.12M | 7.55M | 24.24M | |||
| Other Financing Activity | -80.00K | -3.57M | -2.09M | -700.00K | -70.00K | |||
| FINANCING CASH FLOW | -80.00K | 28.68M | 22.03M | 6.86M | 24.17M | |||
| Exchange Rate Effect | N/A | 0.00 | -10.00K | 0.00 | 10.00K | |||
| CHANGE IN CASH | -10.93M | 16.98M | 6.30M | -3.83M | 11.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -10.80M | -11.71M | -15.13M | -10.76M | -7.04M | |||
| Capital Expenditure | -50.00K | 0.00 | 0.00 | 0.00 | -210.00K | |||
| FREE CASH FLOW | -10.85M | -11.71M | -15.13M | -10.76M | -7.25M | |||
All data in USD